SOD1 and frontotemporal dementia: In ALS/FTD, ASOs targeting disease-associated genes such as SOD1,17ataxin-2,18FUS,19 and C9orf72-associated repeat20,21,22 have been investigated and are now being clinically tested for their efficacy and safety in patients.